作为癌症生物学和精准医学新兴参与者,小核核RNAs

相关实验视频

Updated: Jan 9, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method

Published on: October 7, 2025

Hans Kristian Lorenzo^1,2,3

¹INSERM UMR-S-MD 1197, 94803 Villejuif, France.

|December 11, 2025

概括

小核RNAs (snoRNAs) 正在成为癌症生物学中的关键调节者. 失调的snoRNAs可以充当瘤基因或瘤抑制剂,具有作为癌症生物标志物和治疗点的潜力.

科学领域:

分子生物学分子生物学
癌症研究癌症研究
在RNA生物学,RNA生物学.

背景情况:

小核RNAs (snoRNAs) 是一种非编码RNAs,主要以核糖体RNA修饰而闻名.
新出现的证据突出了它们在细胞过程中的多样性作用,超出了rRNA修饰的范围.
最近的研究表明,snoRNAs在癌症生物学上的重要影响.

研究的目的:

审查各种癌症类型中小核核RNA (snoRNA) 失调的新兴证据.
分析snoRNAs为恶性转变做出贡献的分子机制.
讨论snoRNAs作为癌症生物标志物和治疗点的潜力.

主要方法:

关于癌症中snoRNA功能的最近研究的文献综述.
分析分子机制,包括核糖体生物发生,替代拼接和表观遗传调制.
讨论snoRNAs在瘤学中的诊断,预后和治疗应用.

主要成果:

小核RNAs (snoRNAs) 在各种瘤中经常受到失调.
在癌症发展过程中,snoRNAs可以作为瘤基因和瘤抑制剂发挥作用.
机制包括对核糖体生物发生的调节,替代拼接,表观遗传修饰和转录后调节.

结论:

小核RNAs (snoRNAs) 是瘤发生的基本参与者.
失调的snoRNA为非侵入性癌症诊断和预后提供了机会.
斯诺RNAs代表了新型癌症疗法和精准医学的有希望的目标.

关键词:

生物标志物生物标志物癌症生物学癌症生物学没有编码的RNA.核糖体功能障碍核糖体功能障碍这是一个小核核RNARNA.治疗目标是治疗的目标.

更多相关视频

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

相关概念视频

The Nucleolus

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

Ribosomal RNA Synthesis

Ribosomal RNA Synthesis

Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...